RecallRadar

FDA Drug recall D-1702-2012

Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc

On 2012-10-03 the FDA classified a Class II recall of Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc by Mylan Pharmaceuticals, citing adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1702-2012
ClassificationClass II
Statusterminated
Initiated2012-07-27
Published2012-10-03
Last updated2026-09-13 11:51 UTC
CompanyMylan Pharmaceuticals
DistributionKY

Product

Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05

Reason

Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.

Identifiers

ndc0378-5615-78
ndc0378-5615-05
ndc0378-5617-78
ndc0378-5617-05
ndc0378-5619-91
code_infoLot ZLMM12063, Exp March 2014

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1702-2012%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.